EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing therapeutic efficacy through degradation of endogenous extracellular matrix in primary breast tumor spheroids

Alessandra Lo Cicero iD, Simona Campora, Gabriele Lo Buglio, Paolo Cinà, Margot Lo Pinto, Simone Dario Scilabra iD, Giulio Ghersi iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Alessandra Lo Cicero und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Italy. Hauptthemen laut MEDLINE: Spheroids, Cellular, Extracellular Matrix, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of University and Research (MUR) for the PON Project on Research and Innovation 2014-2020 (Azione IV.4-Contratti di ricerca su tematiche dell'Innovazi…, European Union-NextGenerationEU through the Italian Ministry of University and Research under PNRR-MUR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid tumors have a complex extracellular matrix (ECM) that significantly affects tumor behavior and response to therapy. Understanding the ECM's role is crucial for advancing cancer research and treatment. This study established an in vitro model using primary cells isolated from a rat breast tumor to generate three‐dimensional spheroids. Monolayer cells and spheroid cultures exhibited different protein expression patterns, with primary tumor spheroids presenting an increased level of ECM‐related proteins and a more complex extracellular environment. Furthermore, spheroids produce endogenous collagen type I matrix, which is the main component of the tumoral ECM. This matrix is arranged predominantly around the 3D structure, mimicking the conditions of solid tumors. Treatments with recombinant collagenases class II (acting on the linear collagen region) and class I (acting on the 3D‐helix region) completely degrade collagen within the spheroid structure. Collagenase pretreatment enhances the accessibility of the anticancer drug doxorubicin to penetrate the core of spheroids and sensitize them to doxorubicin‐induced cytotoxicity. Our findings highlight the importance of overcoming drug resistance in breast cancer by targeting the ECM and proposing a novel strategy for improving therapeutic outcomes in solid tumors. By employing a three‐dimensional spheroid model, with an endogenous ECM, we can offer more relevant insights into tumor biology and treatment responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spheroids, CellularExtracellular MatrixBreast NeoplasmsAnimalsFemaleRatsDoxorubicinTumor Cells, CulturedCollagenasesCollagen Type IHumans

Stichwörter der Autor:innen

breast cancercollagencollagenasedrug responseextracellular matrixspheroids

Substanzen

DoxorubicinCollagenasesCollagen Type I

Autor:innen und Institutionen

  • Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Italy.
  • Department of Biomedical Engineering Bioscience Center of the University of Cincinnati, OH, USA.
  • Department of Pharmacy, University of Copenhagen, Denmark.
  • Abiel Srl, Palermo, Italy.
  • Proteomics Group of Ri.MED Foundation, Research Department IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, Italy.

ORCID-Profile: Alessandra Lo Cicero, Simone Dario Scilabra, Giulio Ghersi

Förderung

  • Ministry of University and Research (MUR) for the PON Project on Research and Innovation 2014-2020 (Azione IV.4-Contratti di ricerca su tematiche dell'Innovazi…
  • European Union-NextGenerationEU through the Italian Ministry of University and Research under PNRR-MUR

Zitieren

APA

Lo Cicero, A., Campora, S., Lo Buglio, G., Cinà, P., Lo Pinto, M., Scilabra, S. D., & Ghersi, G. (2025). Enhancing therapeutic efficacy through degradation of endogenous extracellular matrix in primary breast tumor spheroids. The FEBS Journal. https://doi.org/10.1111/febs.70069

Vancouver

Lo Cicero A, Campora S, Lo Buglio G, Cinà P, Lo Pinto M, Scilabra SD, et al. Enhancing therapeutic efficacy through degradation of endogenous extracellular matrix in primary breast tumor spheroids. The FEBS Journal. 2025. doi:10.1111/febs.70069

BibTeX
@article{LoCicero2025,
  author = {Lo Cicero, Alessandra and Campora, Simona and Lo Buglio, Gabriele and Cinà, Paolo and Lo Pinto, Margot and Scilabra, Simone Dario and Ghersi, Giulio},
  title = {Enhancing therapeutic efficacy through degradation of endogenous extracellular matrix in primary breast tumor spheroids},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70069}
}
Kostenlos starten →